Y-90 Zevalin Alternatives Compared
| Y-90 Zevalin (ibritumomab) | Rituxan (rituximab) | Rituximab |
|
|---|
| Y-90 Zevalin (ibritumomab) | Rituxan (rituximab) | Rituximab |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Non-Hodgkin's Lymphoma. Y-90 Zevalin may also be used for purposes not listed in this medication guide. |
Prescription only
Rituxan is a CD20 monoclonal antibody that causes B-cells to self-destruct or disintegrate and may be used to treat Non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid... View more |
Prescription only
Rituximab (brand name Rituxan) is a CD20 monoclonal antibody that causes B-cells to self-destruct or disintegrate and may be used to treat Non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia... View more |
Related suggestions Non-Hodgkin's Lymphoma
|
|||||||||||||||
| More about Y-90 Zevalin (ibritumomab) | More about Rituxan (rituximab) | More about Rituximab | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Be the first to share your experience with this drug. |
Rituxan has an average rating of 8.2 out of 10 from a total of 53 ratings on Drugs.com. 79% of reviewers reported a positive effect, while 9% reported a negative effect. |
Rituximab has an average rating of 7.7 out of 10 from a total of 175 ratings on Drugs.com. 69% of reviewers reported a positive effect, while 14% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
|
View all Y-90 Zevalin side effects |
View all Rituxan side effects |
View all Rituximab side effects |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
View all Y-90 Zevalin prices |
View all Rituxan prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||||||||||
| Dosage Forms | ||||||||||||||||||
|
|
N/A |
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Other ibritumomab brands include: Zevalin | Other rituximab brands include: Riabni, Ruxience, Truxima | Riabni, Rituxan, Ruxience, Truxima | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
|
67.3 hours |
59.8 hours |
59.8 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 376 drugs are known to interact with Y-90 Zevalin:
|
A total of 196 drugs are known to interact with Rituxan:
|
A total of 196 drugs are known to interact with Rituximab:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
N/A |
November 26, 1997 |
N/A |
||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient Resources | ||||||||||||||||||
| Professional Resources | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
|
||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Rituxan
Rituxan infusion is used to treat certain leukemias and lymphomas and some non-cancer conditions ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Tavneos
Tavneos (avacopan) is a C5a receptor antagonist used for severe active ANCA-associated vasculitis ...
Ruxience
Ruxience is a biosimilar to Rituxan and is used to treat certain leukemias and lymphomas and some ...
Rasuvo
Rasuvo is used for polyarticular juvenile idiopathic arthritis, psoriasis, rheumatoid arthritis
Bendamustine
Bendamustine is used for chronic lymphocytic leukemia, multiple myeloma, non-hodgkin's lymphoma
Cytarabine
Cytarabine is used for acute myeloid leukemia, acute nonlymphocytic leukemia, chronic myelogenous ...
Vincristine
Vincristine is used for acute lymphocytic leukemia, acute myeloid leukemia, anaplastic ...
Cyclophosphamide
Cyclophosphamide is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, brain ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.